Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 2 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

NOVEL ANTI_CD137 ANTIBODIES AND USES THEREOF

Application WO-2018091740-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.